BRPI0912615A2 - agonistas de receptor y2 e/ou y4 de longa ação - Google Patents

agonistas de receptor y2 e/ou y4 de longa ação

Info

Publication number
BRPI0912615A2
BRPI0912615A2 BRPI0912615A BRPI0912615A BRPI0912615A2 BR PI0912615 A2 BRPI0912615 A2 BR PI0912615A2 BR PI0912615 A BRPI0912615 A BR PI0912615A BR PI0912615 A BRPI0912615 A BR PI0912615A BR PI0912615 A2 BRPI0912615 A2 BR PI0912615A2
Authority
BR
Brazil
Prior art keywords
acting
long
receptor agonists
agonists
receptor
Prior art date
Application number
BRPI0912615A
Other languages
English (en)
Portuguese (pt)
Inventor
Jacob Kofoed
Jane Spetzler
Rasmus Jorgensen
Sanne Moller Knudsen
Soren Ostergaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BRPI0912615A2 publication Critical patent/BRPI0912615A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0912615A 2008-05-16 2009-05-18 agonistas de receptor y2 e/ou y4 de longa ação BRPI0912615A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08156360 2008-05-16
EP09154461 2009-03-05
PCT/EP2009/055989 WO2009138511A1 (en) 2008-05-16 2009-05-18 Long-acting y2 and/or y4 receptor agonists

Publications (1)

Publication Number Publication Date
BRPI0912615A2 true BRPI0912615A2 (pt) 2016-01-26

Family

ID=40934036

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912615A BRPI0912615A2 (pt) 2008-05-16 2009-05-18 agonistas de receptor y2 e/ou y4 de longa ação

Country Status (12)

Country Link
US (1) US20110275559A1 (enExample)
EP (1) EP2279204A1 (enExample)
JP (1) JP2011520847A (enExample)
KR (1) KR20110017874A (enExample)
CN (1) CN102027007A (enExample)
AU (1) AU2009248041B2 (enExample)
BR (1) BRPI0912615A2 (enExample)
CA (1) CA2723855A1 (enExample)
IL (1) IL208836A0 (enExample)
MX (1) MX2010011845A (enExample)
RU (1) RU2504550C2 (enExample)
WO (1) WO2009138511A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2450374B9 (en) 2009-07-02 2016-11-23 Takeda Pharmaceutical Company Limited Peptide and use thereof
CN102573888A (zh) * 2009-09-18 2012-07-11 诺和诺德公司 长效y2 受体激动剂
EP2498800A1 (en) * 2009-11-13 2012-09-19 Novo Nordisk A/S Long-acting y2 receptor agonists
GB201001333D0 (en) * 2010-01-27 2010-03-17 Imp Innovations Ltd Novel compounds and their effects on feeding behaviour
WO2012006566A2 (en) 2010-07-09 2012-01-12 Amylin Pharmaceuticals, Inc. Microcrystalline y receptor agonists
MX377589B (es) 2010-12-16 2025-03-10 Novo Nordisk As Composiciones sólidas que comprenden agonista de glp-1 y sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico.
KR102072202B1 (ko) 2012-03-22 2020-01-31 노보 노르디스크 에이/에스 Ｇｌｐ-1 펩티드의 조성물 및 그것의 제조
RS58039B1 (sr) 2013-05-02 2019-02-28 Novo Nordisk As Oralno doziranje glp-1 jedinjenja
EP2842965A1 (en) 2013-09-03 2015-03-04 Gubra ApS Neuromedin U analogs comprising serum albumin binding amino acid residue
WO2015071355A1 (en) 2013-11-15 2015-05-21 Novo Nordisk A/S Selective pyy compounds and uses thereof
ES2732015T3 (es) * 2013-11-15 2019-11-20 Novo Nordisk As Compuestos de PYY selectivos y sus usos
WO2015073878A1 (en) * 2013-11-15 2015-05-21 Ur Diet, Llc Real-time satiety biofeedback
US10583172B2 (en) 2013-11-15 2020-03-10 Novo Nordisk A/S HPYY(1-36) having a beta-homoarginine substitution at position 35
US20240100450A9 (en) * 2014-01-17 2024-03-28 Repligen Corporation Sterilizing chromatography columns
EP3094391B1 (en) 2014-01-17 2024-11-20 Repligen Corporation Sterilizing chromatography columns
CN114805527A (zh) * 2014-05-21 2022-07-29 哈佛大学的校长及成员们 Ras抑制肽和其用途
MX392572B (es) * 2015-06-12 2025-03-24 Novo Nordisk As Compuestos del péptido yy (pyy) selectivos y sus usos.
AR114353A1 (es) 2018-02-02 2020-08-26 Novo Nordisk As Composiciones sólidas que comprenden un agonista del glp-1 y una sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico
TWI749381B (zh) * 2018-11-01 2021-12-11 美商美國禮來大藥廠 蛋白質酪胺酸-酪胺酸類似物及其使用方法
GB201908426D0 (en) * 2019-06-12 2019-07-24 Imp College Innovations Ltd Appetite suppressing compounds
CA3175725A1 (en) * 2020-04-17 2021-10-21 William Blackwell Long acting peptide tyrosine tyrosine (pyy) analogs and methods of use
JP2024516395A (ja) 2021-04-27 2024-04-15 アードバーク・セラピューティクス・インコーポレイテッド 苦味受容体アゴニストおよび腸シグナル伝達化合物の組み合わせ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2123293A3 (en) * 2000-12-14 2010-09-08 Amylin Pharmaceuticals, Inc. Peptide YY and petide YY agonists for treatment of metabolic disorders
EP1670515A2 (en) * 2003-09-19 2006-06-21 Novo Nordisk A/S Albumin-binding derivatives of therapeutic peptides
EP1789440A4 (en) * 2004-02-11 2008-03-12 Amylin Pharmaceuticals Inc REASONS FOR THE FAMILY OF PANCREATIC POLYPEPTIDES AND POLYPEPTIDES CONTAINING THEM
DK2060266T3 (da) * 2004-03-17 2011-11-14 7Tm Pharma As Y4-selektiv receptoragonist PP2-36 til terapeutiske indgreb
ES2542228T3 (es) * 2004-07-08 2015-08-03 Novo Nordisk A/S Marcas de prolongación polipeptídica que comprenden un resto de tetrazol
CN101222942A (zh) * 2005-07-18 2008-07-16 诺沃-诺迪斯克有限公司 用于治疗肥胖的肽

Also Published As

Publication number Publication date
RU2504550C2 (ru) 2014-01-20
EP2279204A1 (en) 2011-02-02
MX2010011845A (es) 2010-11-22
AU2009248041A1 (en) 2009-11-19
CA2723855A1 (en) 2009-11-19
KR20110017874A (ko) 2011-02-22
IL208836A0 (en) 2011-01-31
WO2009138511A1 (en) 2009-11-19
US20110275559A1 (en) 2011-11-10
AU2009248041B2 (en) 2013-10-03
CN102027007A (zh) 2011-04-20
RU2010149474A (ru) 2012-06-27
JP2011520847A (ja) 2011-07-21

Similar Documents

Publication Publication Date Title
IL208836A0 (en) Long-acting y2 and/or y4 receptor agonists
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
BRPI0922483A2 (pt) agonista de receptor gpr120 e usos dos mesmos
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
PL3722310T3 (pl) Stabilne i rozpuszczalne przeciwciała hamujące vegf
BRPI0911242A2 (pt) conjunto de articulação e/ou mancal
BRPI0921822A2 (pt) composição compreendendo polímero e enzima
PT3037529T (pt) Polipéptidos ph20 estendidos solúveis e suas utilizações
DK2313111T3 (da) Toll-lignende receptoragonistformuleringer og anvendelse deraf
BRPI0913625A2 (pt) articulação esférica
BRPI0912046A2 (pt) composições de hibridização e métodos
BRPI0910925A2 (pt) conjuntos de transferência de líquido e métodos relacionados
ATE476966T1 (de) Feste dispersion mit schwer wasserlöslichem wirkstoff
BRPI0913024A2 (pt) lista de mensagens e painel de leitura de mensagens sincronizados centrados na conversação
BRPI0809978A2 (pt) Dispositivos e métodos de dispensação de gotículas
BRPI0807473A2 (pt) Recipiente, javre e conjunto de recipiente e javre
BRPI0811450A2 (pt) Montagens de dobradiça e de vaso sanitário.
BRPI0807911A2 (pt) Agonistas de alfa2c adrenorreceptor
BRPI0911618A2 (pt) antagonistas da via hedgehog de ftalazina dissubstituída.
EP2284538A4 (en) Biosensor
BRPI0921230A2 (pt) agonistas de receptor de neuropeptídeos-2 (y-2r) e usos dos mesmo.
BRPI0909322A2 (pt) Método e aparelho de gerenciamento de lista
BRPI0914098A2 (pt) biosensor
EP2280284A4 (en) Biosensor
EP2233803A4 (en) SEAL STRUCTURE

Legal Events

Date Code Title Description
B10A Cessation: cessation confirmed

Free format text: HOMOLOGADA A DESISTENCIA DO PEDIDO, SOLICITADA ATRAVES DA PETICAO ELETRONICA WBRJ NO 860140167707 DE 03/10/2014.

B10H Cessation: republication